
CAS 58558-08-0: Saikosaponin B1
Formula:C42H68O13
InChI:InChI=1S/C42H68O13/c1-21-29(47)34(55-35-32(50)31(49)30(48)24(18-43)53-35)33(51)36(52-21)54-28-11-12-38(4)25(39(28,5)19-44)10-13-40(6)26(38)9-8-22-23-16-37(2,3)14-15-42(23,20-45)27(46)17-41(22,40)7/h8-9,21,24-36,43-51H,10-20H2,1-7H3/t21-,24-,25-,26-,27+,28+,29+,30-,31+,32-,33-,34+,35+,36+,38+,39+,40-,41-,42-/m1/s1
InChI key:InChIKey=WRYJYFCCMSVEPQ-MNIDVGFKSA-N
SMILES:C[C@]12C(=C3[C@@](CO)([C@@H](O)C1)CCC(C)(C)C3)C=C[C@]4([C@@]2(C)CC[C@@]5([C@]4(C)CC[C@H](O[C@H]6[C@H](O)[C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@@H](O)[C@@H](C)O6)[C@]5(CO)C)[H])[H]
Synonyms:- (3b,4a,16b)-16,23,28-Trihydroxyoleana-11,13(18)-dien-3-yl-6-deoxy-3-O-beta-D-glucopyranosyl-beta-D-galactopyranoside
- (3beta,16beta)-16,23,28-trihydroxyoleana-11,13(18)-dien-3-yl 6-deoxy-3-O-beta-D-glucopyranosyl-beta-D-galactopyranoside
- (3beta,9xi,16beta)-16,23,28-trihydroxyoleana-11,13(18)-dien-3-yl 3-O-(6-deoxy-beta-D-glucopyranosyl)-beta-D-galactopyranoside
- (3β,4α,16β)-16,23,28-Trihydroxyoleana-11,13(18)-dien-3-yl 6-deoxy-3-O-β-<span class="text-smallcaps">D</smallcap>-glucopyranosyl-β-<smallcap>D</span>-galactopyranoside
- Saikosaponin B<sub>1</sub>
- β-<span class="text-smallcaps">D</smallcap>-Galactopyranoside, (3β,4α,16β)-16,23,28-trihydroxyoleana-11,13(18)-dien-3-yl 6-deoxy-3-O-β-<smallcap>D</span>-glucopyranosyl-
- Saikosaponin B1
- (3β,4α,16β)-16,23,28-Trihydroxyoleana-11,13(18)-dien-3-yl 6-deoxy-3-O-β-D-glucopyranosyl-β-D-galactopyranoside
- β-D-Galactopyranoside, (3β,4α,16β)-16,23,28-trihydroxyoleana-11,13(18)-dien-3-yl 6-deoxy-3-O-β-D-glucopyranosyl-
Sort by
Found 7 products.
Saikosaponin B1
CAS:Saponin activator. Activates release of Prostaglandin E2 in vitro. Anti-inflammatory agent. Orally active. Active in vivo and in vitro.Formula:C42H68O13Purity:98.07% - 99.7%Color and Shape:SolidMolecular weight:780.98Saikosaponin b1
CAS:Natural glycosideFormula:C42H68O13Purity:≥ 90.0 % (HPLC)Color and Shape:PowderMolecular weight:781Saikosaponin B1
CAS:Saikosaponin B1 may be as anti-schizophrenic candidate drugs, it can suppress the signal transduction after binding of EGF.Formula:C42H68O13Purity:95%~99%Molecular weight:780.993b-D-Galactopyranoside,(3b,4a,16b)-16,23,28-trihydroxyoleana-11,13(18)-dien-3-yl6-deoxy-3-O-b-D-glucopyranosyl-
CAS:Formula:C42H68O13Purity:98%Color and Shape:SolidMolecular weight:780.98152Saikosaponin B1
CAS:Saikosaponin B1 is a triterpenoid saponin, which is primarily derived from the roots of Bupleurum species, particularly Bupleurum falcatum. This bioactive compound exhibits a plethora of pharmacological activities through various modes of action, including modulation of immune responses and inhibition of inflammatory pathways. It interacts with cellular components to influence signal transduction mechanisms that are crucial in the pathophysiology of various diseases. Research has demonstrated its potential applications in the treatment of inflammatory and immune-related conditions due to its ability to suppress the production of pro-inflammatory cytokines and mitigate oxidative stress. Additionally, Saikosaponin B1 has shown promise in antiviral therapies, as it can interfere with viral replication processes. Its diverse capabilities make it a compound of significant interest in the development of novel therapeutic agents.Purity:Min. 95%